The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 418,575 ordinary shares in the Company, representing 1.31% of the Company’s current issued share capital. 33.48% of the issued share capital is not in public hands. The Company is aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:

Number of ordinary shares % of issued share capital
Schroder Investment Management Limited 16.58%
Obotritia Capital KGaA 15.63%
Arthurian Life Sciences SPV GP Ltd, as GP of The Wales Life Sciences Investment Fund LP 9.42%

The above information was last updated on Thursday, 13 August 2020